Inui H, Mizuno J, Kikuchi E, Noguchi K, Tanji Y, Hamabata M, Kotsuzumi C, Komiyama M, Noguchi Y, Tamura M
Inui Institute for Frontier Reproductive Medicine and Infertility, Inui Maternity Clinic, Koriyama, Fukushima, Japan.
Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Cryo Letters. 2019 Jan/Feb;40(1):1-10.
Vitrification is widely used for assisted reproductive technology (ART). Most vitrification devices require the skillful placement of embryos into the carrier and aspiration of excessive vitrification solution.
To evaluate the efficacy and safety of the Cryoroom as a vitrification device.
Mouse and human embryos were vitrified with Cryoroom or Cryotop, and the developmental potency was assessed in vitro. Mouse monozygotic twin blastocysts were vitrified with Cryoroom or Cryotop for microarray analysis.
In mouse and human embryos, there were no differences between the survival and developmental progress in each device. In silico, the Cryoroom device showed no changes, particularly in DNA methylation after vitrification compared with the Cryotop. These results showed that the form and function of the device may affect the gene expression levels in vitrified embryos.
The Cryoroom represents a safe and potentially revolutionary vitrification device for ART.